Previous Article | Next Article ![]()
Applied and Environmental Microbiology, January 2006, p. 776-783, Vol. 72, No. 1
0099-2240/06/$08.00+0 doi:10.1128/AEM.72.1.776-783.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Produce Safety and Microbiology Research Unit, U.S. Department of Agriculture, Agricultural Research Service, 800 Buchanan St., Albany, California 94710
Received 28 June 2005/ Accepted 7 October 2005
|
|
|---|
|
|
|---|
Variable traits of L. monocytogenes serotype 4b and 1/2a strains have been described previously. Buncic et al. (5) showed that at 4°C, serotype 1/2a strains survived exposure to bacteriocins better than serotype 4b strains. Additionally, serotype 4b strains survived heat treatments immediately following cold storage better than serotype 1/2a strains. Genome sequence comparisons between a serotype 1/2a strain and multiple serotype 4b strains revealed serotype-specific genes and showed that the serotype 1/2a strain genome is slightly larger than the serotype 4b strain genomes (14). Analysis of the genotypic differences between the serotypes has led to subtyping of the species into three genetic lineages, based on ribotyping, virulence gene analysis, and mixed-genome microarray analysis (1, 2, 9, 21, 22). Bruhn et al. (4) recently described a bias in favor of lineage 2 strains (which include serotype 1/2a strains) over lineage 1 strains (which include serotype 4b strains) in the commonly used enrichment broth media, University of Vermont Listeria enrichment media I and II (UVM I and II).
Another of the standard protocols used to enrich L. monocytogenes from food samples is the U.S. Food and Drug Administration (FDA) Bacterial Analytical Manual (BAM) method (8). The BAM L. monocytogenes enrichment protocol includes a nutrient-rich primary enrichment medium, buffered Listeria enrichment broth (BLEB), into which food samples are inoculated. After a 4-h incubation to allow for the recovery of stressed cells, two antibiotics (nalidixic acid and cycloheximide) and a toxic dye (acriflavine) are added. The cycloheximide is used to reduce fungal growth, the nalidixic acid eliminates many gram-negative bacteria, and the acriflavine eliminates many gram-positive bacteria, especially fecal enterococci. The culture is then incubated for two more days before it is plated on one of four approved selective and differential agar media. The entire process can take a few days to a week. Many food diagnostic laboratories use either this method or a variation of it to isolate potential L. monocytogenes colonies for further analysis by phenotypic and/or molecular methods. Prior to establishment of the antibiotic enrichment protocols in the late 1980s, L. monocytogenes enrichment was a simple, but lengthy, process that took advantage of the ability of the species to grow at 4°C. Enrichments were done in rich medium in a refrigerator and could take months. No single enrichment protocol is best, as studies that have compared different enrichment protocols as well as direct plating of contaminated foods side by side have shown that some strains are recovered by one method and not by another (11, 19). Studies have also shown that use of two independent enrichment protocols yields more isolates than use of one protocol alone (18, 19).
The antibiotic enrichments have made isolation easier. However, since genetic and phenotypic differences between serotypes have been established, it is reasonable to think that these differences could extend to the enrichment process, a stressful environment that demands coping with antibiotics and competition with normal food microbiota. Since serotype 1/2a strains are isolated from foods more often than serotype 4b strains and since the two serotypes have physiological and genetic differences, we speculated that differences in fitness related to serotype might also occur in common selective enrichment protocols. Our hypothesis was that serotype 1/2a strains are not more common in foods but rather are more fit in the enrichment protocol and thus outcompete any serotype 4b strains that may also be present. We tested this hypothesis with a set of eight L. monocytogenes strains using the FDA BAM enrichment protocol. We selected both serotype 1/2a strains and serotype 4b strains that had been isolated from patients, animals, food, and silage. Some of the strains were cultured originally before the standard antibiotic enrichment protocols were developed and were included to determine how well they competed with more recent strains isolated by antibiotic enrichment. We inoculated enrichment broth media with mixed cultures of serotype 1/2a and 4b strains with and without added foods to determine if either serotype survived the enrichment protocol better than the other. The colonies of the two serotypes were differentiated with a colony immunoblot assay that we developed previously (16). This study differs from a study described recently (4) because a different enrichment medium was used, foods were added to the enrichment process, the entire enrichment protocol (liquid enrichment and plating on selective agar) was used, and a much larger number of colonies were assessed.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Strains used in this study
|
Doubling times and adaptation to supplement stress.
Doubling times of cultures in different media were measured by monitoring the A600 of cultures growing in BLEB and BLEB containing BAM supplements. Cultures were grown overnight in the same medium in which they were to be monitored, diluted 1:50 into fresh medium, and incubated at 30°C with shaking at 100 rpm, and the A600 was monitored. The doubling time was calculated by determining the time that it took for the A600 value to double during the logarithmic phase. The time that it took to respond to chemical stress was determined by diluting a BLEB-grown culture into fresh BLEB, allowing it to grow for 90 min, and then adding the BAM supplements. The A600 values of the cultures were monitored and compared to see if there were differences in growth or adaptation to the antimicrobial agents. The experiments were done at least twice, and the average values and standard deviations were calculated.
|
|
|---|
90 min in BLEB containing supplements. |
View this table: [in a new window] |
TABLE 2. Doubling times of cultures of L. monocytogenes in BLEB and in BLEB containing antibiotic and chemical supplements
|
![]() View larger version (13K): [in a new window] |
FIG. 1. Growth of cultures in BLEB before and after addition of BAM supplements. The time of addition of the supplements is indicated by an arrow. See text for details.
|
![]() View larger version (66K): [in a new window] |
FIG. 2. Typical immunoblot with mixed serotype colonies of L. monocytogenes. The pink colonies are RM2387 colonies (serotype 4b), and the blue colonies are RM3364 colonies (serotype 1/2a).
|
![]() View larger version (23K): [in a new window] |
FIG. 3. Percentages of serotype 4b and 1/2a strains resulting from mixed enrichments in BLEB without added food. Shaded bars, serotype 4b strains; open bars, serotype 1/2a strains. The serotype 1/2a strains are indicated on the x axes. (A) RM2387 versus serotype 1/2a strains; (B) RM2199 versus serotype 1/2a strains; (C) RM3176 versus serotype 1/2a strains.
|
![]() View larger version (25K): [in a new window] |
FIG. 5. Percentages of serotype 4b and 1/2a strains resulting from mixed enrichments in BLEB with lettuce. Shaded bars, serotype 4b strains; open bars, serotype 1/2a strains. The serotype 1/2a strains are indicated on the x axes. (A) RM2387 versus serotype 1/2a strains; (B) RM2199 versus serotype 1/2a strains; (C) RM3176 versus serotype 1/2a strains.
|
![]() View larger version (27K): [in a new window] |
FIG. 4. Percentages of serotype 4b and 1/2a strains resulting from mixed enrichments in BLEB with cheese. Shaded bars, serotype 4b strains; open bars, serotype 1/2a strains. The serotype 1/2a strains are indicated on the x axes. (A) RM2387 versus serotype 1/2a strains; (B) RM2199 versus 1/2a strains; (C) RM3176 versus 1/2a strains.
|
Whereas RM3106 and RM3175 were the two serotype 1/2a strains that were the least competitive in the mixed enrichments overall with the serotype 4b strains, the two serotype 1/2a strains that consistently proved to be more fit in the enrichments in comparisons with all three serotype 4b strains were milk isolate RM2985 and silage isolate RM3316. The latter two strains were both isolated originally with antimicrobial supplements. RM2985 and RM3316 consistently dominated the L. monocytogenes populations recovered from the different enrichments in which they were used (Fig. 3 to 5). In pairs with the serotype 4b strains incubated in plain medium, RM2985 and RM3316 each accounted for over 90% of the colonies recovered. When foods were added, the recovery of serotype 4b strains RM2387 and RM2199 was slightly better in pairs with serotype 1/2a strains RM2985 and RM3316 than in plain medium (approximately 20% to 30%). The third serotype 4b strain, RM3176, however, was still poorly recovered from the food enrichments when it was paired with either RM2985 or RM3316. In these pairs, only 0% to 4% of the colonies recovered were RM3176 colonies. While RM2985 and RM3316 were among the strains that were recovered best from all enrichments, their doubling times were equivalent to those of many of the other strains in this study, including the three serotype 4b strains (Table 2).
RM3364 was the serotype 1/2a strain that exhibited intermediate fitness in enrichment mixtures with the serotype 4b strains compared with the "high-fitness" serotype 1/2a strains RM2985 and RM3316 and the "low-fitness" serotype 1/2a strains RM3106 and RM3175. Strain RM3364 (serotype 1/2a), which was isolated originally in 1926 without the use of antimicrobial agents, was more fit than any of the serotype 4b strains in enrichments containing media without added food, accounting for 60% to 96% of the colonies on the MOX agar plates (Fig. 3). RM3364 was still recovered at levels of 94% to 98% when it was paired with RM3176 in enrichments with cheese and lettuce. However, the other two serotype 4b strains, RM2387 and RM2199, competed better with RM3364 in the food enrichments. For the RM2387/RM3364 pair in cheese and lettuce, statistically equivalent numbers of each strain were recovered. Statistically equivalent numbers of RM2199 (serotype 4b) and RM3364 (serotype 1/2a) were recovered when this strain pair was grown in enrichments with cheese; however, with lettuce only 20% of the colonies recovered were serotype 4b strain RM2199 colonies (Fig. 4 and 5).
Table 3 shows the log CFU/ml of each strain recovered from all the types of enrichments when the strain was either in coculture or was subjected to the enrichment process in a single culture. Each strain grew to equivalent levels when it was inoculated in monoculture into plain medium or cheese or lettuce enrichments; the levels were roughly 9.5 to 9.6 log CFU/ml in plain medium, 8.5 to 8.8 log CFU/ml in enrichments with cheese, and 9.5 to 10 CFU/ml in enrichments with lettuce. Therefore, strains that were poor competitors in mixed cultures, such as serotype 1/2a strains RM3106 and RM3175 and serotype 4b strain RM3176, were recovered at the same levels as strains that were good competitors when they were enriched as monocultures. In coculture enrichments, when the values for log CFU/ml recovered of each strain were averaged, the number was lower and the standard deviation was greater than when the strains were enriched in single cultures.
|
View this table: [in a new window] |
TABLE 3. Numbers of CFU/ml of strains present in different enrichments when they were cultured alone and in coculturea
|
|
|
|---|
Although only a limited number of strains were tested here, it is clear that some strains were more competitive or more fit than others, but the difference was not correlated with serotype. Two serotype 1/2a strains, RM2985 and RM3316, were high-fitness strains in any pair and in any food (or nonfood) source, whereas other serotype 1/2a strains (e.g., RM3175 and RM3106) exhibited lower fitness. The least fit strain, RM3175, had the shortest doubling time of the strains in this study, and this may be one reason for its low fitness overall in the FDA BAM protocol. However, RM3106, another low-fitness serotype 1/2a strain, had doubling times equivalent to those of the serotype 4b strains tested, and the very-high-fitness serotype 1/2a strain RM2985 had one of the longer doubling times in BLEB containing supplements. Therefore, differences in fitness cannot be attributed to differences in growth rate alone. Potential differences in fitness could be attributed to the ability of a strain to survive the entire 48-h enrichment process; however, as shown in Table 3, all the strains produced similar numbers of cells in monoculture enrichments. Differences in the total number of cells of a given strain were seen only when the cells were mixed in a coculture, Therefore, the individual abilities to survive the 48-h enrichment culture do not explain the differences seen in coculture. These data suggest that there were fitness differences in coculture as a result of competition between L. monocytogenes strains, as well as any complexities added by the presence of foods. Another area of potential difference could be the plating efficiency of the strains on MOX agar, but in our experience L. monocytogenes strains have the same plating efficiency on MOX agar as on the nonselective medium TSYE agar (data not shown).
For the comparison of the coculture enrichments with plain media to the coculture enrichments with added foods, several aspects are worth noting. First, the variability in the data was smaller with plain media. This is understandable considering that the addition of food adds factors that could affect growth and/or fitness, including resident food microbiota, nutrients, inhibitors, and chemicals (e.g., pesticides and preservatives). Second, in some instances the fitness of strain pairs changed with the addition of foods. The serotype 4b strain RM2199 was more fit than some of the serotype 1/2a strains with food in the enrichments. The serotype 1/2a strain RM3364 was recovered at higher levels in plain medium than in the food enrichments when it was paired with the serotype 4b strain RM2387. RM3364 was also more fit in pairings with serotype 4b strain RM2199 in lettuce than in cheese. It should be noted that RM2199, although a human isolate, resulted from an outbreak associated with contaminated cheese. Additional variables in the enrichment, such as the presence of food and/or another L. monocytogenes strain, seemed to challenge the fitness of a strain.
The three strains that were most fit were serotype 1/2a strains RM2985 and RM3316 and serotype 4b strain RM2387, all of which were environmental isolates (isolated from bulk milk, silage, and mint, respectively) that were isolated originally using antimicrobial enrichments (Table 1). Several investigators have described persistent or recurrent strains of L. monocytogenes that are routinely found in processing plants or agricultural environments (7, 10, 12, 15). Presumably, these persistent strains are well suited to their environments and also potentially to the enrichment procedures with which they are routinely found. The very fit strain RM2985 has been identified as a persistent strain in a previous study (3).
Another aspect to consider when competitive fitness is assessed is how the strains were originally isolated. Environmental and food isolates obtained since the late 1980s are most likely to have been isolated using antimicrobial agent-based enrichments similar to that used here. We included patient isolates in part because they were more likely to have been isolated by methods not requiring selective enrichment culture, especially if they were isolated from normally sterile body fluids. Similarly, RM3364 was included since it is an old isolate, not found with the present antimicrobial enrichments, to see if it could compete in the current protocols. While the original antimicrobial agent-based enrichments were developed and tested with older strains, the colony immunoblot method provided a way to test these strains directly in mixed cultures with recent isolates with a large number of colonies to analyze. The serotype 1/2a strain RM3364 proved to be a midlevel competitor with the serotype 4b strains overall, doing very well in plain media and with foods. On the other hand, none of the human isolates (serotype 4b strains RM2199 and RM3176 and serotype 1/2a strain RM3175), which were also isolated from non-antimicrobial agent enrichments, were among the fittest isolates in this study. Therefore, with the limited number of strains tested here, it is difficult to conclude that the FDA BAM enrichment protocol is inherently biased against the strains not isolated with the use of antimicrobial agents. The possibility that clinical isolates might be less fit in enrichment culture than nonclinical isolates is an avenue for future studies.
A previous study reported a bias toward serotype 1/2a strains over serotype 4b strains in UVM I and UVM II, which are enrichment media that are different from the medium used here (4). BLEB has a slightly higher nutrient content (higher concentrations of tryptone and yeast extract, with addition of soytone, dextrose, and pyruvate) than UVM I and II. Additionally, BLEB contains twice as much nalidixic acid as both UVM media and less acriflavine (BLEB, 10 ml/liter acriflavine; UVM I, 12 mg/liter; UVM II, 25 mg/liter). Bruhn et al. (4) speculated that acriflavine might be a cause of the bias in the UVM media; however, when we tested our strains in BLEB containing either 10 or 12 mg/liter acriflavine, there was no difference in growth of any of the strains with the two different acriflavine concentrations (data not shown). Therefore, the lack of bias seen in the present study may be related to nutrient factors present in BLEB that are absent or present at lower concentrations in UVM and/or to the strains used in the studies. The lack of serotype or lineage bias seen here with the BLEB enrichments suggests that BLEB might facilitate isolation of more L. monocytogenes strains present in food than the UVM I and UVM II dual-enrichment protocol. We modified the BAM protocol in one area and incubated the MOX agar plates for 3 days instead of 2 days, so that the colonies of the slowly growing strain RM3175 would be visible. Since RM3175 was originally a human clinical isolate, we recommend that the BAM method should be amended to allow slowly growing, potentially disease-causing isolates to grow on selective agar plates. Nevertheless, with the limited number of strains tested here, we observed that certain strains of L. monocytogenes were more likely to be isolated than others with the FDA BAM enrichment protocol but that the difference was not attributable to serotype or lineage. This may have been due to differences in fitness that are related to the ability of a strain to survive in a given niche and that do not necessarily make it ideally suited to survive enrichment culture when it is competing with a more fit strain.
This research was funded by the U.S. Department of Agriculture (Agricultural Research Service CRIS project number 5325-42000-040-00D).
|
|
|---|
ebam/bam-10.html.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»